-transparent.png){kind=logo}
The effect of tenofovir disoproxil fumarate (TDF) in combination with two boosted fosamprenavir regimens on amprenavir pharmacokinetic parameters was assessed in this prospective phase I crossover study with 30 healthy volunteers. The co-administration of TDF 300 mg once a day with fosamprenavir/ritonavir 1400/200 mg or 1400/100 mg once a day has no effect on the pharmacokinetics of amprenavir and results in non-significant increases of ritonavir pharmacokinetic parameters, suggesting that no dose modification is necessary when combining fosamprenavir/ritonavir with TDF.
Related Publications
Michael Kurowski, and
Ravi K Walli, and
Antje Breske, and
Guido Kruse, and
Hartmut Stocker, and
Norbert Banik, and
Heinz Richter, and
Dago Mazur
March 2010,
HIV medicine,
Michael Kurowski, and
Ravi K Walli, and
Antje Breske, and
Guido Kruse, and
Hartmut Stocker, and
Norbert Banik, and
Heinz Richter, and
Dago Mazur
August 2007,
Antimicrobial agents and chemotherapy,
Michael Kurowski, and
Ravi K Walli, and
Antje Breske, and
Guido Kruse, and
Hartmut Stocker, and
Norbert Banik, and
Heinz Richter, and
Dago Mazur
January 2007,
Antiviral therapy,
Michael Kurowski, and
Ravi K Walli, and
Antje Breske, and
Guido Kruse, and
Hartmut Stocker, and
Norbert Banik, and
Heinz Richter, and
Dago Mazur
January 2005,
Drugs,
Michael Kurowski, and
Ravi K Walli, and
Antje Breske, and
Guido Kruse, and
Hartmut Stocker, and
Norbert Banik, and
Heinz Richter, and
Dago Mazur
June 2007,
AIDS (London, England),
Michael Kurowski, and
Ravi K Walli, and
Antje Breske, and
Guido Kruse, and
Hartmut Stocker, and
Norbert Banik, and
Heinz Richter, and
Dago Mazur
March 2020,
Antimicrobial agents and chemotherapy,
Michael Kurowski, and
Ravi K Walli, and
Antje Breske, and
Guido Kruse, and
Hartmut Stocker, and
Norbert Banik, and
Heinz Richter, and
Dago Mazur
January 2009,
HIV clinical trials,
Michael Kurowski, and
Ravi K Walli, and
Antje Breske, and
Guido Kruse, and
Hartmut Stocker, and
Norbert Banik, and
Heinz Richter, and
Dago Mazur
May 2006,
Journal of acquired immune deficiency syndromes (1999),
Michael Kurowski, and
Ravi K Walli, and
Antje Breske, and
Guido Kruse, and
Hartmut Stocker, and
Norbert Banik, and
Heinz Richter, and
Dago Mazur
June 2007,
Expert review of anti-infective therapy,
Michael Kurowski, and
Ravi K Walli, and
Antje Breske, and
Guido Kruse, and
Hartmut Stocker, and
Norbert Banik, and
Heinz Richter, and
Dago Mazur
January 2006,
Clinical pharmacokinetics,
